Daily multinutrient support in a no-pill Molecular Spray format. Nutrioz Multivitamin Oral Spray is powered by Molecular Spray Technology® — a 0.06 ml fine mist supplement format designed for oral mucosa contact, precision micro-dosing, and easier daily use without pill swallowing. Nutrioz Molecular Spray Technology® is designed for oral mucosa absorption through a 0.06 ml micro-volume spray format. It is not a swallowed tablet or capsule. No pills. No capsules. No water required. Powered by Molecular Spray Technology® 240 sprays per bottle 0.06 ml per spray Fine mist supplement format Designed for oral mucosa contact No pill swallowing required Daily multinutrient support Made in the USA Third-party tested for quality and purity Use only as directed on the product label These statements have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Science Transparency Evidence & Bioavailability Status Nutrioz Multivitamin Oral Spray — Molecular Spray Technology® Delivery Mechanism Nutrioz Multivitamin Molecular Spray is designed as a daily no-pill multinutrient format using Molecular Spray Technology®. Each spray delivers 0.06 ml of active formula directly to the oral mucosa — no tablets, no capsules, no water required. ☆ Spray volume: 0.06 ml per spray ☆ Bottle volume: 14.4 ml ☆ Total sprays: 240 (14.4 ml ÷ 0.06 ml) ⚠ Serving size: To be confirmed — verify sprays per serving before publication ☆ Absorption route: Oral mucosa (sublingual/buccal) Published Study Status Nutrioz-specific published clinical bioavailability study: Not yet published. Scientific Context A multivitamin contains multiple nutrients with different molecular properties. The best validation approach is a structured marker-based and user-adherence study. Each nutrient in the panel may require its own validated biomarker for meaningful clinical assessment. Next Validation Target A user-adherence and nutrient-status pilot measuring daily use consistency, user preference versus pills/capsules, and selected blood markers depending on the final nutrient panel. ☆ Study type: User-adherence and nutrient-status pilot ☆ Primary outcomes: Daily use consistency, user preference vs pills/capsules ☆ Secondary outcomes: Selected blood markers (dependent on final nutrient panel) ⏳ Status: Planned / Not yet initiated Evidence Status Specification Data Available ✔ Product specification sheets available ✔ Delivery mechanism rationale documented ✔ Quality and manufacturing documentation available ⏳ Clinical bioavailability studies: In progress / Not yet published Nutrioz does not hide what is proven and what is still being validated.
Related
Related
Related
Related